Health Results Based Financing Impact Evaluation 2015, Health Facility Baseline Survey
Congo, Dem. Rep., 2015 - 2016
Get Microdata
Reference ID
COD_2015_HRBFIE-FBL_v01_M
Producer(s)
Gil Shapira, Gunther Fink
Collection(s)
Metadata
Created on
Apr 18, 2017
Last modified
Jun 13, 2017
Page views
337544
Downloads
24135
[14.01_other] Pr (f1_14_01_other)
Data file: facility_f1_data
Overview
Valid:
31
Invalid:
0
Type:
Discrete
Start:
9111
End:
9180
Width:
70
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ASRAMES | 1 |
3.2%
|
|
| Achat dans des Pharmacies privée | 1 |
3.2%
|
|
| Acheter a kinshasa. | 1 |
3.2%
|
|
| CAMEBASU | 1 |
3.2%
|
|
| CENTRE HOSPITALIER MATILI | 1 |
3.2%
|
|
| Camibaso | 1 |
3.2%
|
|
| Communaute. | 1 |
3.2%
|
|
| Compagnie qui nous approvisionne | 1 |
3.2%
|
|
| Dépôt camebasu | 1 |
3.2%
|
|
| Dépôt de la ville | 1 |
3.2%
|
|
| Dépôt pharmaceutique | 1 |
3.2%
|
|
| Dépôt pharmaceutique privée | 1 |
3.2%
|
|
| Il y a pas encore une pharmacie fonctionnelle dans le nouveau batiment | 1 |
3.2%
|
|
| La CTB. (Coperation Technique Belge). | 1 |
3.2%
|
|
| Le dépôt pharmaceutique de la SNCC | 1 |
3.2%
|
|
| Matamba solo service de santé communautaire | 1 |
3.2%
|
|
| Medecin sans frontiere. | 1 |
3.2%
|
|
| PARSS,partenaires techniques et financiers,PESS | 1 |
3.2%
|
|
| PARTENAIRE PRIVE MEDECIN SANS FRONTIERE | 1 |
3.2%
|
|
| Partenaire, l'etat congolais | 1 |
3.2%
|
|
| Partenaires | 1 |
3.2%
|
|
| Personne de bonne volonté | 1 |
3.2%
|
|
| Pharmacie privée | 1 |
3.2%
|
|
| Prince Pharma Pharmaquina | 1 |
3.2%
|
|
| achat au depot particulier | 1 |
3.2%
|
|
| ce lieux d'approvisinnement en medicaments n'existe pas | 1 |
3.2%
|
|
| centre de santé de reference | 1 |
3.2%
|
|
| marche local | 1 |
3.2%
|
|
| mbandaka.bikoro | 1 |
3.2%
|
|
| pas de place | 1 |
3.2%
|
|
| pharma | 1 |
3.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.